Topical anti-inflammatory and analgesic activities of standardized pomegranate rind extract in comparison with its marker compound ellagic acid in vivo J Mo, P Panichayupakaranant, N Kaewnopparat, A Nitiruangjaras, ... Journal of ethnopharmacology 148 (3), 901-908, 2013 | 84 | 2013 |
Scutellarin protects against vascular endothelial dysfunction and prevents atherosclerosis via antioxidation J Mo, R Yang, F Li, X Zhang, B He, Y Zhang, P Chen, Z Shen Phytomedicine 42, 66-74, 2018 | 65 | 2018 |
Recent developments in studies of l-stepholidine and its analogs: chemistry, pharmacology and clinical implications J Mo, Y Guo, YS Yang, JS Shen, GZ Jin, X Zhen Current medicinal chemistry 14 (28), 2996-3002, 2007 | 65 | 2007 |
Wound healing activities of standardized pomegranate rind extract and its major antioxidant ellagic acid in rat dermal wounds J Mo, P Panichayupakaranant, N Kaewnopparat, A Nitiruangjaras, ... Journal of natural medicines 68, 377-386, 2014 | 57 | 2014 |
L-stepholidine reduced L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease J Mo, H Zhang, LP Yu, PH Sun, GZ Jin, X Zhen Neurobiology of aging 31 (6), 926-936, 2010 | 54 | 2010 |
Topical anti‐inflammatory potential of standardized pomegranate rind extract and ellagic acid in contact dermatitis J Mo, P Panichayupakaranant, N Kaewnopparat, S Songkro, ... Phytotherapy research 28 (4), 629-632, 2014 | 42 | 2014 |
Proteolysis-targeting chimera against BCL-XL destroys tumor-infiltrating regulatory T cells R Kolb, U De, S Khan, Y Luo, MC Kim, H Yu, C Wu, J Mo, X Zhang, ... Nature communications 12 (1), 1281, 2021 | 36 | 2021 |
Ginsenoside Rg1 ameliorates palmitic acid-induced insulin resistance in HepG2 cells in association with modulating Akt and JNK activity J Mo, Y Zhou, R Yang, P Zhang, B He, J Yang, S Li, Z Shen, P Chen Pharmacological Reports 71, 1160-1167, 2019 | 21 | 2019 |
Geraniin promotes osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) via activating β-catenin: a comparative study between BMSCs from normal and … J Mo, R Yang, F Li, B He, X Zhang, Y Zhao, Z Shen, P Chen Journal of natural medicines 73, 262-272, 2019 | 21 | 2019 |
Physicochemical properties, in vitro release and skin permeation studies of a topical formulation of standardized pomegranate rind extract. J Mo, N Kaewnopparat, S Songkro, P Panichayupakaranant, ... Pakistan journal of pharmaceutical sciences 28 (1), 2015 | 13 | 2015 |
Natural and synthetic estrogens in chronic inflammation and breast cancer CK Maharjan, J Mo, L Wang, MC Kim, S Wang, N Borcherding, P Vikas, ... Cancers 14 (1), 206, 2021 | 11 | 2021 |
Gibberellin derivative GA-13315 sensitizes multidrug-resistant cancer cells by antagonizing ABCB1 while agonizes ABCC1 J Mo, M Kang, JX Ye, JB Chen, H Zhang, C Qing Cancer chemotherapy and pharmacology 78, 51-61, 2016 | 8 | 2016 |
Chronic exposure to the gibberellin derivative GA‑13315 sensitizes breast cancer MCF‑7 cells but not colon cancer HCT116 cells to irinotecan X Cheng, G Wang, Y Liao, J Mo, C Qing Oncology Letters 20 (6), 1-1, 2020 | 3 | 2020 |
Abstract LB410: Contrasting roles of different mismatch repair proteins in basal like breast cancer TI Tithi, J Mo, W Zhang Cancer Research 84 (7_Supplement), LB410-LB410, 2024 | | 2024 |
PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy L Wang, Y Xiao, Y Luo, RP Master, J Mo, MC Kim, Y Liu, CK Maharjan, ... Journal of Experimental Medicine 221 (3), e20231519, 2024 | | 2024 |
Contrasting roles of different mismatch repair proteins in basal-like breast cancer J Mo, N Borcherding, S Jo, TI Tithi, E Cho, KE Cash, M Honda, L Wang, ... bioRxiv, 2023 | | 2023 |
Unleashing the Power of NR4A1 Degradation as a Novel Strategy for Cancer Immunotherapy L Wang, Y Xiao, Y Luo, RP Master, J Mo, MC Kim, Y Liu, UM Patel, X Li, ... bioRxiv, 2023 | | 2023 |